Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Zeltiq Aesthetics, MGH Initiate Patent Lawsuit Against Clinipro - Quick Facts

RELATED NEWS
Trade ZLTQ now with 

Medical technology company Zeltiq Aesthetics, Inc. (ZLTQ: Quote) and the charitable trust of Massachusetts General Hospital or MGH initiated a patient infringement lawsuit in France against Clinipro and its French representative.

In its suit, Zeltiq alleged infringement of a European patent for CoolSculpting technology owned by Massachusetts General Hospital and licensed to Zeltiq and sought monetary damages and an injunction against further sales of Clinipro's LipoCryo device. Zeltiq said the CoolSculpting technology is protected by numerous patents and trademarks around the world.

Click here to receive FREE breaking news email alerts for ZELTIQ Aesthetics, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth. A Thai company has bought iconic U.S. tuna brand Bumble Bee for $1.51 billion dollars. Thai Union Frozen Products Public Company Limited or TUF, the world's largest processor of shelf-stable tuna products snapped up Bumble Bee from private equity firm Lion Capital. Post Synergies, the transaction... Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.